Scarica l'app Stockscreener
0.5084
0.35%
-0.0018
Dopo l'orario di chiusura:
.51
0.0016
+0.31%
Precedente Chiudi:
$0.5102
Aprire:
$0.505
Volume 24 ore:
3.05M
Relative Volume:
0.45
Capitalizzazione di mercato:
$59.16M
Reddito:
-
Utile/perdita netta:
$-119.76M
Rapporto P/E:
-0.3766
EPS:
-1.35
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
-4.08%
1M Prestazione:
-10.96%
6M Prestazione:
-91.89%
1 anno Prestazione:
-93.13%
Intervallo 1D:
$0.50
$0.529
Intervallo di 1 settimana:
$0.4882
$0.59
Portata 52W:
$0.4882
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Nome
Applied Therapeutics Inc
Settore
Industria
Telefono
212-220-9226
Indirizzo
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Confronta APLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.5084 | 59.16M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Downgrade | UBS | Buy → Neutral |
| 2024-11-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Iniziato | William Blair | Outperform |
| 2024-03-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-22 | Iniziato | Leerink Partners | Outperform |
| 2022-01-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Downgrade | Goldman | Neutral → Sell |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2020-10-08 | Iniziato | Truist | Buy |
| 2020-04-22 | Iniziato | Goldman | Buy |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2019-06-10 | Iniziato | Citigroup | Buy |
| 2019-06-10 | Iniziato | Cowen | Outperform |
| 2019-06-10 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Applied Therapeutics Inc Borsa (APLT) Ultime notizie
APLT stock touches 52-week low at $0.54 amid sharp annual decline By Investing.com - Investing.com South Africa
APLT stock touches 52-week low at $0.54 amid sharp annual decline - Investing.com
Applied Therapeutics Inc (APLT) At $0.58 Is Well Worth Your Time - Stocks Register
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
2025-02-18 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your RightsAPLT - PR Newswire
Applied Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Business Wire
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank - GlobeNewswire
2025-02-18 | Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - Lelezard
2025-02-18 | Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:APLT | Press Release - Stockhouse Publishing
Levi & Korsinsky Notifies APLT Investors of Class Action Lead Plaintiff Deadline: February 18, 2025 - The Octant
Deadline on February 18th coming up in Lawsuit for Investors in Applied Therapeutics, Inc. (NASDAQ: APLT) - openPR
2025-02-17 | Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. ... - The Bakersfield Californian
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Stockhouse Publishing
2025-02-17 | Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:APLT | Press Release - Stockhouse Publishing
INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAPLT - PR Newswire
APLT COURT NEWS: Applied Therapeutics has been Sued for - GlobeNewswire
2025-02-16 | Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit - Morningstar
2025-02-16 | Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAPLT - Stockhouse Publishing
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
2025-02-16 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-02-16 | Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT) - GlobeNewswire Inc.
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights - The Bakersfield Californian
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit | FinancialContent Business Page - Financial Content
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - StreetInsider.com
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT) | FinancialContent Business Page - Financial Content
SG Americas Securities LLC Has $35,000 Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
2025-02-14 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics Inc [APLT] Records 50-Day SMA of $0.8519 - Knox Daily
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT) | FinancialContent Business Page - Financial Content
APLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
2025-02-14 | Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-02-14 | Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - Morningstar
APLT SHAREHOLDER ACTION: Applied Therapeutics 80% Stock - GlobeNewswire
2025-02-13 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied - GlobeNewswire
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
2025-02-13 | Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics Inc Azioni (APLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Applied Therapeutics Inc Azioni (APLT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
| Funtleyder Leslie D. | Chief Financial Officer |
Aug 22 '24 |
Sale |
5.83 |
13,530 |
78,880 |
277,911 |
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
0.22%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):